Search Results - "Furusato, B"

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation by Sun, C, Dobi, A, Mohamed, A, Li, H, Thangapazham, R L, Furusato, B, Shaheduzzaman, S, Tan, S-H, Vaidyanathan, G, Whitman, E, Hawksworth, D J, Chen, Y, Nau, M, Patel, V, Vahey, M, Gutkind, J S, Sreenath, T, Petrovics, G, Sesterhenn, I A, McLeod, D G, Srivastava, S

“…The high prevalence of TMPRSS2-ERG rearrangements (∼60%) in prostate cancer (CaP) leads to androgenic induction of the ETS -related gene ( ERG ) expression…”
Get full text

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence by Hawksworth, D, Ravindranath, L, Chen, Y, Furusato, B, Sesterhenn, I A, McLeod, D G, Srivastava, S, Petrovics, G

“…Alterations of chromosome 8, including amplification at 8q24 harboring the C-MYC oncogene, have been noted as one of the most common chromosomal abnormalities…”
Get full text

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification by Furusato, B, Tan, S-H, Young, D, Dobi, A, Sun, C, Mohamed, A A, Thangapazham, R, Chen, Y, McMaster, G, Sreenath, T, Petrovics, G, McLeod, D G, Srivastava, S, Sesterhenn, I A

“…Gene fusions prevalent in prostate cancer (CaP) lead to the elevated expression of the ERG proto-oncogene. ERG activation present in 50–70% of prostate tumors…”
Get full text

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression by DeRosa, C A, Furusato, B, Shaheduzzaman, S, Srikantan, V, Wang, Z, Chen, Y, Siefert, M, Ravindranath, L, Young, D, Nau, M, Dobi, A, Werner, T, McLeod, D G, Vahey, M T, Sesterhenn, I A, Srivastava, S, Petrovics, G

“…Background: The majority of prostate cancers (CaP) are detected in early stages with uncertain prognosis. Therefore, an intensive effort is underway to define…”
Get full text

UP-02.195 Clinicopathological Correlation of ERG Protein Expression in Single Focus Prostate Cancer by Sesterhenn, I, Tan, S, Dobi, A, Srivastava, S, McLeod, D, Brassell, S, Furusato, B

Get full text

UP-02.194 Improved Detection of Prostate Cancer by the Combined Application of ERG and AMACR Immunohistochemical Stainings in Prostate Biopsy Specimens by Lee, G, Russell, D, Parker, P, Sesterhenn, I, Cullen, J, Furusato, B, Dobi, A, McLeod, D, Srivastava, S, Moncur, J

Get full text

UP-02.170 Does Prostate Tumor Proximity to Surgical Margin in pT2 Disease Correlate with Biochemical Recurrence or All-cause Mortality? by Sesterhenn, I, Lee, G, Furusato, B, Cullen, J, Brassell, S, Dobi, A, Srivastava, S, McLeod, D

Get full text

MP-05.02: Expression of N-Cadherin in Yolk Sac Tumor of the Testis by Sesterhenn, I, Heidenberg, D, Grinkemeyer, M, Cameronn, D, Furusato, B

Get full text

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion status by Mwamukonda, K, Chen, Y, Ravindranath, L, Furusato, B, Hu, Y, Sterbis, J, Osborn, D, Rosner, I, Sesterhenn, I A, McLeod, D G, Srivastava, S, Petrovics, G

“…TMPRSS2–ERG fusion is the most common oncogenic rearrangement in prostate cancer (CaP). Owing to this chromosomal rearrangement one TMPRSS2 allele loses its…”
Get full text

Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy? by Furusato, B, Rosner, I L, Osborn, D, Ali, A, Srivastava, S, Davis, C J, Sesterhenn, I A, McLeod, D G

“…The objective of this study was to determine the incidence of prostate specific antigen (PSA) relapse in patients with low volume prostate cancer following…”
Get more information

UP-1.097: Osteoblast-Specific Factor 2 as a Putative High-Grade Tumor-Associated Stromal Marker for Prostate Cancer: Identification Through Microarray Technology by Furusato, B, Tsunoda, T, Shaheduzzaman, S, Nau, M, Vahey, M, Petrovics, G, McLeod, D, Naito, S, Srivastava, S, Sesterhenn, I

Get full text

MP-15.14: Elevated Secreted Protein, Acidic, and Rich in Cysteine (SPARC) Expression in Prostate Cancer Correlates with Tumor Metastasis after Radical Prostatectomy by Furusato, B, DeRosa, C, Chen, Y, Ravindranath, L, Cook, C, Cullen, J, Petrovics, G, Srivastava, S, McLeod, D, Sesterhenn, I

Get full text

Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens by Furusato, B, Shaheduzzaman, S, Petrovics, G, Dobi, A, Seifert, M, Ravindranath, L, Nau, M E, Werner, T, Vahey, M, McLeod, D G, Srivastava, S, Sesterhenn, I A

“…Formalin-fixed paraffin-embedded (FFPE) prostate specimens are rich sources of molecular pathological information. However, FFPE-based microarray analysis of…”
Get full text

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression by Derosa, C A, Furusato, B, Shaheduzzaman, S, Srikantan, V, Wang, Z, Chen, Y, Siefert, M, Ravindranath, L, Young, D, Nau, M, Dobi, A, Werner, T, Mcleod, D G, Vahey, M T, Sesterhenn, I A, Srivastava, S, Petrovics, G

Get full text

Quantitative expression profile of PSGR in prostate cancer by Xu, L L, Sun, C, Petrovics, G, Makarem, M, Furusato, B, Zhang, W, Sesterhenn, I A, McLeod, D G, Sun, L, Moul, J W, Srivastava, S

“…PSGR is a novel member of the G-protein-coupled olfactory receptor family. Our initial report showed predominant expression of the PSGR in human prostate gland…”
Get full text

Frequent overexpression of ETS-related gene-1 in prostate cancer transcriptome by Petrovics, G, Liu, A, Shaheduzzaman, S, Furusato, B, Sun, C, Chen, Y, Nau, M, Ravindranath, L, Dobi, A, Srikantan, V, Sesterhenn, I A, McLeod, D G, Vahey, M, Moul, J W, Srivastava, S

Get full text

Reduced expressions of 4N1K-peptide derived from thrombospondin-2 is associated with malignant aggressiveness and prognosis in bladder cancer by Mochizuki, Y, Miyata, Y, Yasuda, T, Nakamura, Y, Matsuo, T, Ohba, K, Furusato, B, Fukuoka, J, Sakai, H

Get full text

Neoadjuvant hormonal therapy for patients with low risk prostate cancer stimulates lymphvessel invasion and shorten biochemical recurrence-free survival periods by Miyata, Y, Mochizuki, Y, Shida, Y, Matsuo, T, Hakariya, T, Ohba, K, Furusato, B, Fukuoka, J, Sakai, H

Get full text

Benign mimics of prostate cancer by Egevad, Lars, Delahunt, Brett, Furusato, Bungo, Tsuzuki, Toyonori, Yaxley, John, Samaratunga, Hemamali

“…The histopathological diagnosis of prostatic adenocarcinoma is challenged by the existence of numerous benign mimics. Most of these lesions have no clinical…”
Get full text

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation by Srigley, John R., Delahunt, Brett, Samaratunga, Hemamali, Billis, Athanase, Cheng, Liang, Clouston, David, Evans, Andrew, Furusato, Bungo, Kench, James, Leite, Katia, MacLennan, Gregory, Moch, Holger, Pan, Chin-Chen, Rioux-Leclercq, Nathalie, Ro, Jae, Shanks, Jonathan, Shen, Steven, Tsuzuki, Toyonori, Varma, Murali, Wheeler, Thomas, Yaxley, John, Egevad, Lars

“…The Gleason Grading system has been used for over 50 years to prognosticate and guide the treatment for patients with prostate cancer. At consensus conferences…”
Get full text